| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.09 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.094 | 0.09 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.09 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.09 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.21 | 0.1 |